Latest news from OHE
The Economics of Innovation in Times of Pandemic: How to Incentivise the Development, Supply, and Continuous Improvement of Innovative Solutions to Fight COVID-19?
The COVID-19 pandemic has highlighted the necessity of finding health solutions in an unprecedentedly short length of time. However, the first treatments, tests and vaccines will only offer partial solutions. Competing follow-on technologies will offer better or complementary health benefits. It is essential that health systems do not put all of their eggs in one basket.
Author: Mikel Berdud, Adrian Towse and Mireia Jofre-Bonet, with collaboration from Maria Errea and Mehmet Bulut
Posted: May 22, 2020, 7:55 am
OHE has been awarded the status of Independent Research Organisation (IRO) by Research Councils UK. This blog comments on the significance of this achievement.
Author: Mireia Jofre-Bonet
Posted: May 20, 2020, 9:33 am
On the occasion of Adam Wagstaff’s death, Professor Tony Culyer reflects on his vast legacy to health economics, from Tony’s perspective of having been Adam’s PhD supervisor as well as a friend and collaborator.
Author: Tony Culyer and Mireia Jofre-Bonet
Posted: May 15, 2020, 8:22 am
A move towards paying multiple prices for medicines (depending on what they are used for) could address a commonly cited problem in drug development and increase patient access. Our latest consulting report investigates whether key stakeholders are onboard.
Author: Amanda Cole
Posted: May 12, 2020, 6:45 am
In place of OHE’s 2020 Annual Lecture, Adrian Towse will give a webinar-lecture on June 25th on payment models for a COVID-19 vaccine. He will be discussing options for funding the development and manufacture of a vaccine, reflecting on their strengths and weaknesses, considering what may happen with no regional or global collaboration. Analysis will consider the work of Gavi and others to cons...
Author: Adrian Towse
Posted: April 29, 2020, 10:30 am
The need for social distancing in light of COVID-19 has led to an unprecedented increase in reliance on digital technologies by both health care providers and patients. While the trend towards digitalisation of health care allows for potential improvements in access, its impact on health outcomes and health inequalities must be carefully considered to ensure they contribute to social welfare an...
Author: Simon Brassel, Kyann Zhang and Mireia Jofre-Bonet
Posted: April 28, 2020, 11:15 am
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support
Research by OHE and the University of Washington into how uncertainty-related novel elements of value could be included in an Augmented Cost-Effectiveness Analysis has been published in Journal of Managed Care & Specialty Pharmacy (JMCP). The research discusses what has been or could be done to measure these elements and looks at empirical research to date.
Author: Bernarda Zamora and Adrian Towse
Posted: April 14, 2020, 9:19 am
Financing and Scaling Innovation for the COVID Fight: A Closer Look at Demand-Side Incentives for a Vaccine
A COVID-19 vaccine is needed now, but timelines (12-18 months) create large market risk. By the time a vaccine is ready, the crisis may have passed. A CGD Note explores three options: business as usual – which may lead to promotion of an inferior vaccine or fierce country competition for supply – and two models (cost- or value-based), with countries pre-committing to purchases meeting specified...
Author: Adrian Towse
Posted: April 1, 2020, 11:04 am
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
This presentation to the Australian Society for Antimicrobials (ASA) meeting in Melbourne, on 27th February 2020 draws on OHE research, funded by the Wellcome Trust, on adapting HTA methods and contracting for new antibiotics. It analyses UK (NICE and NHSE) plans to introduce a subscription model (delinking use of new antibiotics from payments for making the products available) and suggests tha...
Author: Adrian Towse
Posted: March 26, 2020, 10:54 am
The Office of Health Economics ( www.ohe.org ) wishes to recruit a number of well-qualified, highly motivated and energetic junior economists, with particular strengths in health economics, including the economics of health technology assessment, health care systems and/or the life sciences industry.
Posted: March 23, 2020, 3:04 pm